Psych MEQs / SAQs · Child and adolescent psychiatry — eating disorders
Adolescent anorexia nervosa — medical risk, FBT and refeeding (MEQ)
FRANZCP-style MEQ on adolescent AN: criteria, medical risk, refeeding, FBT, fluoxetine boundaries, capacity. FRANZCP-primary, globally tagged.
On this page & tools
Target exams
Model answer
Reveal model answer
(i) Definition and differentials. AN (DSM-5): energy restriction leading to significantly low weight/growth failure; intense fear of weight gain or persistent behaviour interfering with weight gain; body weight/shape disturbance or undue influence on self-evaluation or persistent lack of recognition of seriousness. Amenorrhoea not required. Here: marked loss, restriction, driven exercise, medical sequelae. Differentials: organic (coeliac, IBD, hyperthyroid, diabetes, malignancy), depression, OCD contamination, psychosis, ARFID (no weight phobia), substance misuse. Discriminators: weight/shape overvaluation, fear of fatness, ritualised restriction vs systemic red flags.[5][2]
(ii) Medical risk and admission. Assess HR, orthostatic BP, temperature, hydration, ECG (bradycardia/QTc), electrolytes (K, phosphate, Mg), glucose, rate of loss, ability to eat safely at home, suicide risk. This case shows bradycardia, orthostasis, hypothermia, hypokalaemia, syncope — high medical risk. SAHM-style and Junior MARSIPAN-informed pathways support paediatric medical admission for monitoring and refeeding rather than outpatient hope alone. Do not discharge because she says she is “fine.”[2]
(iii) Refeeding. Protocolised nutrition (local paediatric dietetic pathway); thiamine; frequent phosphate/K/Mg; vitals and ECG as indicated; watch for oedema and arrhythmia. Refeeding syndrome = insulin-driven intracellular electrolyte shifts after carbohydrate reintroduction. StRONG: higher-calorie refeeding achieved faster weight gain without increased refeeding adverse events under monitoring versus lower starts — still requires protocol, not improvisation.[3][6]
(iv) FBT for parents. Externalise AN (illness, not bad parenting). Phase 1: parents take charge of meals/refeeding; unite against illness; stop negotiation with AN rules. Phase 2: gradual return of control as weight restores. Phase 3: adolescent development and relapse prevention. Evidence: Lock RCT FBT superior to AFT at follow-up for remission. Address parental guilt directly — FBT is empowerment, not blame.[1][5]
(v) SSRIs and capacity/legal. Fluoxetine is not indicated as AN weight-restoration or post-weight-restoration relapse prevention drug (Walsh RCT negative). Treat comorbid depression/anxiety later with caution once medical risk addressed. Capacity is decision-specific; starvation and overvalued ideas may impair weighing of medical risk. For minors, parental responsibility and best interests usually guide; if life-saving treatment refused and incapacitous, use local compulsory frameworks (Mental Health Act / child protection / court) — name jurisdiction, do not invent foreign section numbers. Prefer voluntary collaborative care when safe.[4][5]
Common errors
- Requiring amenorrhoea for AN diagnosis.
- Discharging on “not underweight enough” despite unstable vitals.
- Offering fluoxetine as the main AN treatment.
- Blaming parents instead of empowering FBT Phase 1.
- Starting refeeding without phosphate monitoring. [2][4][6]
Examiner notes
High marks require named evidence (Lock; StRONG; Walsh negative) and concrete medical parameters, not generic “admit if severe.” [1][3][4]
References
- [1]Lock J, Le Grange D, Agras WS, et al. Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa Arch Gen Psychiatry, 2010.PMID 20921118
- [2]Society for Adolescent Health and Medicine, Golden NH, Katzman DK, et al. Position Paper of the Society for Adolescent Health and Medicine: medical management of restrictive eating disorders in adolescents and young adults J Adolesc Health, 2015.PMID 25530605
- [3]Garber AK, Cheng J, Accurso EC, et al. Short-term Outcomes of the Study of Refeeding to Optimize Inpatient Gains for Patients With Anorexia Nervosa: A Multicenter Randomized Clinical Trial JAMA Pediatr, 2021.PMID 33074282
- [4]Walsh BT, Kaplan AS, Attia E, et al. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial JAMA, 2006.PMID 16772623
- [5]Hay P, Chinn D, Forbes D, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of eating disorders Aust N Z J Psychiatry, 2014.PMID 25351912
- [6]Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it BMJ, 2008.PMID 18583681